Oramed Pharmaceuticals Inc.(ORMP)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
ORMP is scheduled to report on Nov 11, 2026, usually after the market closes. Analysts expect EPS of $0.44.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±2.6%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 3 misses.
In plain words: it beat expectations 6 times, but the stock still fell 2 of those 6 times.
- Aug '26Beat▲ +1.2%
- Nov '25Beat▼ -2.9%
- Aug '25Beat▼ -1.9%
- May '25Missed▼ -2.3%
- Mar '25Missed▼ -3.9%
- Nov '24Missed▼ -2.9%
- Aug '24Beat▲ +4.9%
- May '24Beat▲ +0.8%
- Aug '23Beat▲ +2.5%
Clear beats and misses with a known reaction only. What counts as a beat
Why did ORMP fall after beating earnings?
2 of ORMP's last 9 reactions went against the EPS result. What stands out in each:
ORMP beat EPS estimates in 6 quarters, and the stock still closed lower the next day 2 times.
- Nov 13, 2025EPS beat +2925.0%stock -2.9% next day
- It had risen 5.7% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.1% lower as soon as trading resumed.
- Aug 14, 2025EPS beat +875.0%stock -1.9% next day
- It opened 5.7% lower as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was ORMP's earnings move already priced in?
ORMP's move in the month before each of its last 9 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 9 reports. Green or red: the day after.
Past reports only. How the run-up is measured
What the history says
- ORMP has beaten EPS estimates in 3 straight quarters.
ORMP earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | After close | $0.43 | $1.84 | +327.9% | +1.19% | +4.29% |
| Mar 26, 2026 | After close | — | $0.25 | — | — | — |
| Nov 13, 2025 | After close | -$0.04 | $1.13 | +2925.0% | -2.92% | +3.75% |
| Aug 14, 2025 | After close | -$0.04 | $0.31 | +875.0% | -1.89% | -2.83% |
| May 15, 2025 | After close | -$0.01 | -$0.19 | -1800.0% | -2.27% | -2.27% |
| Mar 27, 2025 | After close | -$0.02 | -$0.26 | -1200.0% | -3.91% | -7.39% |
| Nov 7, 2024 | After close | -$0.02 | -$0.48 | -2300.0% | -2.94% | -1.68% |
| Aug 14, 2024 | After close | -$0.02 | $0.22 | +1200.0% | +4.91% | +5.80% |
| May 9, 2024 | After close | $0.02 | $0.04 | +100.0% | +0.84% | +3.78% |
| Mar 6, 2024 | After close | -$0.01 | $0.33 | +3400.0% | — | — |
| Nov 9, 2023 | After close | -$0.09 | -$0.08 | +11.1% | — | — |
| Aug 10, 2023 | After close | -$0.09 | -$0.03 | +66.7% | +2.51% | -1.88% |
Consensus for the next report: EPS $0.44, revenue $0.00.
ORMP Earnings FAQ
Answers computed from Oramed Pharmaceuticals Inc.'s reported history
ORMP is scheduled to report on Nov 11, 2026, usually after the market closes. Analysts expect EPS of $0.44.
Over the last 11 quarters with a usable EPS surprise, ORMP beat the consensus estimate 8 times (73%), missed 3 and landed in line 0. It has beaten estimates in each of the last 3 counted quarters.
Across its last 9 quarters with a measured reaction, ORMP moved an average of ±2.6% in the first session after reporting. It closed higher 44% of the time; the largest gain was 4.9% and the largest drop -3.9%.
ORMP fell in the first session after 2 of its last 6 EPS beats (33%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 9 quarters with price data, ORMP moved an average of -0.3% in the 20 trading sessions before reporting and was higher in 33% of them. After a run-up of 3% or more (3 quarters), it fell the next day 67% of the time, averaging -1.9%. After a drop of 3% or more (3 quarters), it rose the next day 100% of the time, averaging +2.8%. This describes past reports; it is not a forecast.
How we calculate these numbers · ORMP: 12 reported quarters, latest Aug 10, 2026. Information only, not investment advice.
Looking for more on ORMP?
Price charts, forecast, fundamentals and risk pages for ORMP are not on Tickzen yet. You can run a full stock analysis now.
Run the ORMP Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun